Contract Research Organization (CRO) Services Market


Contract Research Organization (CRO) Services Market

 Category : Pharmaceutical

 Published: Aug-2021
 Author: SPER Analyst

The contract research organization (CRO) services market is projected to be worth around USD 88.5 Billion by 2027

The global contract research organization (CRO) services market is expected to grow at a CAGR of 11.4% from 2020 to reach USD 88.5 billion by 2027. The growth is primarily attributed to increasing investment in pharmaceutical R&D, increasing number of clinical trials and rising incidence of orphan and rare diseases. Retaining highly skilled professionals is a significant challenge to the growth of this market.

Browse report overview on "Contract Research Organization (CRO) Services Market" at:

The global CRO services market study provides market data for-by type (early phase development services, clinical research services, laboratory services, consulting services and data management services), by therapeutic area (oncology, infectious diseases, neurology, CVS, metabolic disorders/endocrinology, immunological disorders, respiratory disorders, psychiatry, dermatology, haematology, ophthalmology, gastrointestinal, genitourinary & women’s health and other therapeutic areas), by molecule type (vaccines, cell & gene therapy diseases and other molecule types) and by end user (pharmaceutical & biotechnology companies, medical device companies and academic institutes). The study also evaluates industry competitors and analyses the market at a regional and country level.

Clinical research services segment dominated the CRO services market in 2020 and will show similar trend in the forecast period. The largest share of this market is mainly due to growing geriatric population, prevalence of chronic diseases and growing demand for newer drugs. 

By therapeutic area, oncology segment accounted for the largest share of CRO services market in 2020 and is expected to follow similar trend in forecast period. The large share is mainly attributed to high incidence of cancer and pipeline of drugs in late-stage development. 

By molecule type, cell & gene therapy segment accounted for fastest growth of CRO services market. The growth is mainly related to rising R&D expenditure in regenerative medicine and promising therapies in pipeline. 

Don’t miss out on business opportunities in the global contract research organization (CRO) services market. Request customized report as per your need and gain crucial industry insights that will help your business grow at:

On the basis of end users, pharmaceutical & biopharmaceutical market segment held largest share of CRO services market in 2020. This is primarily due to increasing outsourcing of early-phase development services and clinical & laboratory testing services by pharmaceutical companies. 

This research report analyses major geographies and provides a comprehensive analysis of North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, India, Japan, and RoAPAC), Rest of the world (Latin America, and Middle East & Africa). North America accounted for the largest share of the global CRO services market. The large growth of this market is attributed to presence of leading pharmaceutical & biopharmaceutical companies and high investments in the biologics segment. Europe is expected to be the second lead regional market for CRO services in the forecast period.

The major players operating in the global CRO services market are 
  • IQVIA (US)
  • LabCorp (US)
  • Charles River Laboratories (US)
  • WuXi AppTec (China)
  • Syneos Health (US)
  • Parexel International (US)
  • PPD (US)
  • ICON Plc (US)
  • Medpace Holdings (US)
  • SGS (Switzerland)
  • Axcent Advanced Analytics (US)
  • BIO Agile Therapeutics (US)
  • Firma Clinical Research (US)
  • Acculab Life Sciences (US)
  • Azelix (US)
  • CTserv (US)
  • Pepgra (UK)
  • Dove Quality Solutions (US)
  • Novotech Health Holding (Australia)
  • Geneticist Inc. (US)
  • Linical Americas (US)
  • Frontage Holding Corporation (US)
  • and Celerion (US)

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Johnson & Johnson


Market Research

We are the leading, full-service global market research and consulting company.

iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]